Back to News
Jan 6, 2026 4:00 PM

Why Is Medtronic Stock Trading Higher After Analyst Upgrade

On Tuesday, William Blair upgraded Medtronic Plc (NYSE:MDT), citing several new and ramping launches.

William Blair upgraded from Market Perform to Outperform. Analyst Brandon Vazquez wrote that the Market Perform rating hinged on a business that was too large and not differentiated enough to durably hit its goals of delivering consistent high-single-digit EPS growth.

Medtronic is ramping up several new products, with many more in the pipeline.

Medtronic's Transformation: A Turning Point Ahead

If Medtronic is truly positioned for high-single-digit EPS growth, then the company can deliver low-double-digit equity return when factoring in a 2.9% dividend yield.

Also Read: FDA Flags Medtronic Heart Catheter Recall As Most Serious Safety Risk

"At a valuation of roughly 16 times calendar 2026 EPS, the stock is trading in line to slightly below large-cap medtech peers, suggesting a favorable risk/reward for an improving setup," Vazquez added.

The Hugo system has been ...